SBI Securities’s Aethlon Medical AEMD Stock Holding History

SBI Securities’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Hold	0	–	-$1	–	4018
2025 Q3	–	Hold	0	–	–	–	4160
2025 Q2	–	Hold	0	–	–	–	4121
2025 Q1	–	Sell	-2	Closed	-$466	–	3910
2024 Q4	$714	Buy	+2	New	+$339	﹤0.01%	2754

Other funds holding AEMD

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

SBI Securities's AEMD Position: Q4 2025 in Review

SBI Securities held its Aethlon Medical (AEMD) position steady in Q4 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4018.

SBI Securities first reported a position in AEMD in Q4 2024 and has held it in 1 quarter since. The position peaked at $714 in Q4 2024. 7 funds tracked by Wall St. Rank hold AEMD as of Q4 2025.

SBI Securities held 0 shares of Aethlon Medical worth $0 as of Q4 2025.
SBI Securities left its Aethlon Medical share count unchanged in Q4 2025.
Aethlon Medical made up ﹤0.01% of SBI Securities's portfolio in Q4 2025, its #4018 holding.
SBI Securities first reported a position in Aethlon Medical in Q4 2024 and has held it in 1 quarter since.
SBI Securities's Aethlon Medical position peaked at $714 in Q4 2024.
7 funds tracked by Wall St. Rank held Aethlon Medical as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.